RJA
NUVA

Raymond James & Associates’s NuVasive, Inc. NUVA Stock Holding History

Raymond James & Associates’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-34,470
Closed -$1.43M – 3978
2023
Q2 		$1.43M Buy
34,470
+1,288
+4% +$52.9K ﹤0.01% 2267
2023
Q1 		$1.37M Buy
33,182
+2,748
+9% +$118K ﹤0.01% 2260
2022
Q4 		$1.26M Buy
30,434
+532
+2% +$21.5K ﹤0.01% 2300
2022
Q3 		$1.31M Sell
29,902
-3,395
-10% -$165K ﹤0.01% 2235
2022
Q2 		$1.64M Buy
33,297
+6,474
+24% +$347K ﹤0.01% 2119
2022
Q1 		$1.52M Buy
26,823
+2,185
+9% +$116K ﹤0.01% 2316
2021
Q4 		$1.29M Sell
24,638
-17,750
-42% -$965K ﹤0.01% 2457
2021
Q3 		$2.54M Sell
42,388
-4,101
-9% -$253K ﹤0.01% 1931
2021
Q2 		$3.15M Sell
46,489
-882
-2% -$60.2K ﹤0.01% 1796
2021
Q1 		$3.11M Buy
47,371
+7,959
+20% +$477K ﹤0.01% 1736
2020
Q4 		$2.22M Buy
39,412
+297
+0.8% +$14.6K ﹤0.01% 1825
2020
Q3 		$1.9M Sell
39,115
-5,127
-12% -$276K ﹤0.01% 1797
2020
Q2 		$2.46M Sell
44,242
-501
-1% -$29K ﹤0.01% 1606
2020
Q1 		$2.27M Sell
44,743
-3,070
-6% -$206K ﹤0.01% 1498
2019
Q4 		$3.7M Sell
47,813
-792
-2% -$55.9K ﹤0.01% 1446
2019
Q3 		$3.08M Buy
48,605
+41,530
+587% +$2.6M ﹤0.01% 1535
2019
Q2 		$414K Sell
7,075
-1,841
-21% -$109K ﹤0.01% 2811
2019
Q1 		$506K Sell
8,916
-4,336
-33% -$230K ﹤0.01% 2637
2018
Q4 		$657K Sell
13,252
-28,162
-68% -$1.69M ﹤0.01% 2353
2018
Q3 		$2.94M Buy
41,414
+229
+0.6% +$14.6K ﹤0.01% 1564
2018
Q2 		$2.15M Sell
41,185
-610
-1% -$32K ﹤0.01% 1715
2018
Q1 		$2.18M Buy
41,795
+126
+0.3% +$6.39K ﹤0.01% 1642
2017
Q4 		$2.44M Buy
41,669
+1,689
+4% +$95.8K ﹤0.01% 1564
2017
Q3 		$2.22M Sell
39,980
-1,983
-5% -$131K ﹤0.01% 1579
2017
Q2 		$3.23M Sell
41,963
-7,206
-15% -$539K 0.01% 1267
2017
Q1 		$3.67M Buy
49,169
+3,023
+7% +$219K 0.01% 1174
2016
Q4 		$3.11M Buy
46,146
+278
+0.6% +$17.9K 0.01% 1227
2016
Q3 		$3.06M Buy
45,868
+17,859
+64% +$1.14M 0.01% 1211
2016
Q2 		$1.67M Sell
28,009
-854
-3% -$46.2K 0.01% 1436
2016
Q1 		$1.4M Sell
28,863
-40
-0.1% -$1.81K ﹤0.01% 1495
2015
Q4 		$1.56M Buy
28,903
+1,926
+7% +$98.2K 0.01% 1396
2015
Q3 		$1.3M Buy
26,977
+7,441
+38% +$385K 0.01% 1457
2015
Q2 		$926K Buy
+19,536
New +$913K ﹤0.01% 1779

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Raymond James & Associates's NUVA Position: Q3 2023 in Review

Raymond James & Associates sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 34,470 shares — an estimated $1.43M sold.

Raymond James & Associates first reported a position in NUVA in Q2 2015 and held it in 33 quarters. The position peaked at $3.7M in Q4 2019. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Raymond James & Associates reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Raymond James & Associates sold 34,470 NuVasive, Inc. shares in Q3 2023, an estimated $1.43M.
  • Raymond James & Associates first reported a position in NuVasive, Inc. in Q2 2015 and held it in 33 quarters.
  • Raymond James & Associates's NuVasive, Inc. position peaked at $3.7M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Raymond James & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.